(Q34484083)

2 August 2017

1 reference

title

Ivermectin: pharmacology and application in dermatology (English)

1 reference

2 August 2017

0 references

1 reference

Assen L Dourmishev

1

1 reference

PubMed ID

16409259

2 August 2017

Lyubomir A Dourmishev

series ordinal

2

1 reference

PubMed ID

16409259

2 August 2017

Robert A Schwartz

series ordinal

3

1 reference

2 August 2017

1 December 2005

1 reference

International Journal of Dermatology

2 August 2017

1 reference

2 August 2017

44

1 reference

2 August 2017

12

1 reference

2 August 2017

981-988

1 reference

Ivermectin: a new therapeutic weapon in dermatology?

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Efficacy and tolerance of ivermectin in human onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

A field study of the effects of ivermectin on ectoparasites of man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

The treatment of scabies with ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin for crusted (Norwegian) scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Effects of perinatal ivermectin exposure on behavioral development of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin: a few caveats are warranted before initiating therapy for scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: general overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Efficacy of topically applied ivermectin against sarcoptic mange (Sarcoptes scabiei var. bovis) of cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Systemic treatment of white-tailed deer with ivermectin-medicated bait to control free-living populations of lone star ticks (Acari:Ixodidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Efficacy and tolerance of oral ivermectin in scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

The use of ivermectin in controlling an outbreak of scabies in a prison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

[Oral treatment of scabies with ivermectin]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Oral ivermectin in scabies patients: a comparison with 1% topical lindane lotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Deaths associated with ivermectin treatment of scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin-responsive crusted scabies in HTLV1 carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin for crusted Norwegian scabies induced by use of topical steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Norwegian scabies in a patient with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin for Sarcoptes scabiei hyperinfestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

21 January 2018

Ivermectin for scabies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Our scabies treatment is archaic, but ivermectin has arrived.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Oral ivermectin in the treatment of scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Scabies therapy for the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Systemic activity of ivermectin on the human body louse (Anoplura: Pediculidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

An assessment of topical and oral prescription and over-the-counter treatments for head lice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Efficacy of Ivermectin in the Therapy of Cutaneous Larva Migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Efficacy of ivermectin in the therapy of larva currens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Myiasis: a successful treatment with topical ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Lack of adverse reactions in ivermectin treatment of onchocerciasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

A trial of a three-dose regimen of ivermectin for the treatment of patients with onchocerciasis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Safety of and compliance with community-based ivermectin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Expatriates treated with ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Deaths associated with ivermectin for scabies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Absence of ivermectin-associated excess deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

Ivermectin for spasticity in spinal-cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02253.X

10.1111/J.1365-4632.2004.02253.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16409259